Evidence map›Paper›PMID 41855442›Full record

ArticleJCO global oncology2026

Treatment Decision Making at Diagnosis for Children Presenting With Advanced Cancer in Low- and Middle-Income Countries.

Marta Salek, Ana Caceres-Serrano, Joanne Canedo, Lucia Fuentes, Shoshana Mehler, Alaina Rule, Jamie Zeal, Carlos Rodriguez-Galindo, Dylan Graetz, Nickhill Bhakta and 2 more

Abstract read
In one paragraph

Article in JCO global oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marta SalekSt Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-3421-5945
Ana Caceres-SerranoUnidad Nacional de Oncologia Pediatrica, Guatemala City, Guatemala.ORCID 0000-0001-8139-2170
Joanne CanedoUniversity of Mississippi, Oxford, MS.
Lucia FuentesUnidad Nacional de Oncologia Pediatrica, Guatemala City, Guatemala.
Shoshana MehlerSt Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-9854-6305
Alaina RuleUniversity of Tennessee Health Science Center, Memphis, TN.
Jamie ZealUniversity of North Carolina-Chapel Hill, Chapel Hill, NC.ORCID 0000-0003-2102-8101
Carlos Rodriguez-GalindoSt Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-2360-8946
Dylan GraetzSt Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-4541-6910
Nickhill BhaktaSt Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-5282-7833
Erica C KayeSt Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-6522-3876
CATALYST Advisory Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough most children diagnosed with cancer live in low- and middle-income countries (LMICs), research exploring decision making in these settings remains sparse. When children present with advanced cancer in LMICs, local centers may lack resources to provide treatment required to achieve cure. Existing treatment guidelines often do not account for contextual and resource variations influencing decision making. This qualitative study sought to understand physician approaches to treatment decision making for children presenting with advanced cancer at diagnosis in LMICs.

methodsSemistructured interviews were conducted with 36 physicians caring for children with cancer across all world regions and representing diverse income levels. Interviews were conducted in English, audio-recorded, and transcribed. Inductive content analysis focused on decision-making approaches.

resultsMost participants were female (n = 24; 67%), older than 36 years (n = 32; 89%), and practiced at centers caring for >100 new childhood cancer cases annually (n = 26; 72%) in lower-middle-income countries (n = 20; 55%). A spectrum of cancers were reported as advanced at diagnosis, with no single diagnosis predominating. Physicians generally recommended four treatment approaches (eg, curative-intent, non-curative-intent, referral, or limited chemotherapy trial), resulting in seven outcome pathways based on whether a family accepted, challenged, or declined the proposed treatment. Four decision-making approaches (eg, physician-led, family-led, participatory, or externally influenced) informed determinations of goals of care focused on optimizing prognostic outcomes, providing individualized care, and committing to treating all children, irrespective of differences in patient/family circumstances.

conclusionPhysicians caring for children with cancer in LMICs navigate complex treatment decision making, considering diverse treatment paths and goals. Pragmatic, evidence-based interventions are needed to guide decision making, flexible to local constraints.

Indexed as

Clinical Decision-MakingDeveloping CountriesNeoplasmsPhysiciansAdultChildFemaleHumansInterviews as TopicMaleMiddle AgedPatient Care PlanningQualitative Research

Identifiers

PMID41855442
PMCPMC13035103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.